Differential immunoregulation by human surfactant protein A variants determines severity of SARS-CoV-2-induced lung disease

Salma Mahmoud

doi:10.3389/fimmu.2025.1462278

Differential immunoregulation by human surfactant protein A variants determines severity of SARS-CoV-2-induced lung disease

Salma Mahmoud

Cite this

Salma Mahmoud, (2025), Differential immunoregulation by human surfactant protein A variants determines severity of SARS-CoV-2-induced lung disease, FRONTIERS IN IMMUNOLOGY

BibTeX RIS (EndNote, Zotero, Mendeley)

SUZA researcher

Salma Abdi MahmoudDean-School of Health and Medical sciencesDepartment of Obstetrics and Gynaecology